ReviewHaematologica2024

Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults.

Tobias Feuchtinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.